Memon Fehmida, Aijaz Samia, Bhatti Mahreen, Sheikh Naheed
Dr. Fehmida Memon, FCPS Associate Professor, Liaquat University of Medical and Health Sciences, Hyderabad, Sindh, Pakistan.
Dr. Samia Aijaz, FCPS Consultant Urogynaecologist, Liaquat University of Medical and Health Sciences, Hyderabad, Sindh, Pakistan.
Pak J Med Sci. 2024 Oct;40(9):2096-2100. doi: 10.12669/pjms.40.9.8184.
To identify the risk factors for cardiovascular disease in women with pre-eclampsia and intrauterine growth retardation.
This cross sectional study was conducted in Department of Gynecology and Obstetrics, Liaquat University Hospital, Hyderabad, from April 2022 to October 2022. Patients with history of intrauterine growth retardation or preeclampsia after 20 weeks of gestation, age more than 18 years were included in this study. Patients were assessed for cardiovascular risk factors during pregnancy.
The average age and gestational age were almost equal in preeclampsia and IUGR patients, (p≤0.050). The primparous were higher in preeclampsia than IUGR, n=286 (73.5%) and n=80 (52.3%), respectively, (p=0.000). The average birth weight of IUGR was lower than preeclampsia patients, 925.19±6.35 gram and 1324.76±10.19 gram, respectively, (p=0.000). The average systolic and diastolic blood pressure of IUGR patients was less than preeclampsia patients, (p=0.000). But, the chronic hypertension was higher in preeclampsia patients n=99 (25.4%) as compare to IUGR n=13 (8.5%) patients, (p=0.000). The average cholesterol level in IUGR was 5.52±0.58(mmol/L) versus preeclampsia 5.34±1.01(mmol/L), (p=0.043). The average triglycerides was almost equal in both the groups, (p=0.924). The mean Lp(a) in preeclampsia patients was 177.15±20.15(mg/L) versus 202.94±24.83 (mg/L), (p=0.000).
Findings of this study help conclude that women with known history of IUGR or preeclampsia must be screened for possible cardiovascular risk factors and treated for these risk factors in order to avoid future mortality and morbidity associated with cardiovascular diseases.
确定患有子痫前期和胎儿宫内生长受限的女性心血管疾病的危险因素。
本横断面研究于2022年4月至2022年10月在海得拉巴利亚卡特大学医院妇产科进行。纳入妊娠20周后有胎儿宫内生长受限或子痫前期病史、年龄超过18岁的患者。在孕期对患者进行心血管危险因素评估。
子痫前期和胎儿宫内生长受限患者的平均年龄和孕周几乎相等,(p≤0.050)。子痫前期初产妇比例高于胎儿宫内生长受限患者,分别为n = 286(73.5%)和n = 80(52.3%),(p = 0.000)。胎儿宫内生长受限患者的平均出生体重低于子痫前期患者,分别为925.19±6.35克和1324.76±10.19克,(p = 0.000)。胎儿宫内生长受限患者的平均收缩压和舒张压低于子痫前期患者,(p = 0.000)。但是,子痫前期患者中慢性高血压的比例为n = 99(25.4%),高于胎儿宫内生长受限患者n = 13(8.5%),(p = 0.000)。胎儿宫内生长受限患者的平均胆固醇水平为5.52±0.58(mmol/L),子痫前期患者为5.34±1.01(mmol/L),(p = 0.043)。两组的平均甘油三酯水平几乎相等,(p = 0.924)。子痫前期患者的平均脂蛋白(a)为177.15±20.15(mg/L),而胎儿宫内生长受限患者为202.94±24.83(mg/L),(p = 0.000)。
本研究结果有助于得出结论,有胎儿宫内生长受限或子痫前期病史的女性必须筛查可能的心血管危险因素,并针对这些危险因素进行治疗,以避免未来与心血管疾病相关的死亡率和发病率。